Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
29.43%
↑ 314% vs avg
Percentile
P71
Within normal range
Streak
5 yr
Consecutive growthAccelerating
Average
-13.78%
Historical baseline
PeriodValue
202529.43%
202413.28%
2023-9.91%
2022-54.13%
2021-118.41%
2020-177.98%
2019-35.54%
2018306.30%
2017-18.26%
2016-72.57%